Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:27:07.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed, replacing the previous v3.4.1. This appears to be a backend/UI maintenance update with no visible changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:20.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Minor version update from Revision: v3.4.0 to v3.4.1 with no visible changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:31:13.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Show glossary and minor copy changes (including a Revision: v3.4.0 note and capitalization tweaks) were added; these changes do not affect study data or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:18:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T04:30:35.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:55:29.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.